Applicability of an absolute quantitative procedure to monitor intra- individual bcr/abl transcript kinetics in clinical samples from chronic myelogenous leuigemia patients

International Journal of Cancer

Volumn 86, Issue 5, 2000, Pages 741-746

  Kreuzer, Karl Anton ^a   Lass, Ulrich ^a   Nagel, Stefan ^a   Ellerbrok, Heinz ^b   Pauli, Georg ^b   Pawlaczyk Peter, Bärbel ^a   Siegert, Wolfgang ^a   Huhn, Dieter ^a   Schmidt, Christian Andreas ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; BETA ACTIN; CHIMERIC PROTEIN; COMPLEMENTARY DNA; HYBRID PROTEIN;

ARTICLE; BLOOD SAMPLING; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION;

DISEASE PROGRESSION; FUSION PROTEINS, BCR-ABL; HUMANS; KINETICS; LEUKEMIA, MYELOID, CHRONIC; QUALITY CONTROL; REFERENCE STANDARDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034061249     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000601)86:5<741::AID-IJC22>3.0.CO;2-1     Document Type: Article

References (25)

1. CHOMCZYNSKI, P., and SACCHI, N., Single-step method of RNA isolation by acid guanidinium thioeyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
2. CROSS, N.C.P., FENG, L., CHASE, A., BUNGEY, J., HUGHES, T.P., and GOLDMAN, J.M., Competitive polymerase chain reaction to estimate the number of ber-abl transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood, 82, 1929-1936 (1993).
3. DHINGRA, K., TALPAZ, M., KANTARJIAN, H., KU, S., ROTHBERG, J., GUTTERMANN, J.U., and KURZROCK, R., Appearance of acute leukemia-associated p190bcr-abl in chronic myelogenous leukemia may correlate with disease progression. Leukemia, 5, 191-195 (1991).
4. DROBYSKI, W.R., ENDEAN, D.J., KLEIN, J.P., and HESSNER, M.J., Detection of bcr/abl RNA transcripts using the polymerase chain reaction is highly predictive for relapse in patients transplanted with unrelated marrow grafts for chronic myelogenous leukaemia. Br. J. Haematol., 98, 458-466 (1997).
5. GABERT, J., LAFAGE, M., MARANINCHI, D., THURET, I., CARCASSONNE, Y., and MANNONI, P., Detection of residual bcr/abl translocation by polymerase chain reaction in chronic myeloid leukemia patients after bone-marrow transplantation. Lancet, 2, 1125-1128 (1989).
6. GUO, J.Q., WANG, J.Y.J., and ARLINGHAUS, R.B., Detection of bcr-abl proteins of benign phase chronic myelogenous leukemia patients. Cancer Res., 51, 3048-3051 (1991).
7. HUGHES, T.P., JANSSEN, J.W.G., MORGAN, G., MARTIAT, P., SAGLIO, G., PIGNON, J.M., PIGNATTI, F.P., MILLS, K., KEATING, A., GLUCKMAN, E., BARTRAM, C.R., and GOLDMAN, J.M., False positive results with PCR to detect leukaemia-specific transcripts. Lancet. 335, 1037-1038 (1990).
8. KREUZER, K.A., LASS, U., BOHN, A., LANDT, O., and SCHMIDT, C.A., LightCycler technology for the quantitation of bcr/abl fusion transcripts. Cancer Res., 59, 3171-3174 (1999a)
9. KREUZER, K.A., LASS, U., LANDT, O., NITSCHE, A., ELLERBROK, H., PAULI, G., SIEGERT, W., HUHN, D., and SCHMIDT, C.A., Highly sensitive and specific fluorescence RT-PCR assay for the pseudogene free detection of β-actin transcripts as quantitative reference. Clin. Chem., 45, 297-300 (1999b).
10. LANGE, W., SNYDER, D.S., CASTRO, R., ROSSI, J.J., and BLUME, K.G., Detection of enzymatic amplification of bcr-abl mRNA in peripheral blood and bone marrow cells of patients with chronic myelogenous leukemia. Blood, 73, 1735-1740 (1989).
11. LEE, M. KHOURI, I., CHAMPLIN, R., KANTARJIAN, H., TALPAZ, M., TRUJILLO, J., FREIREICH, E., DEISSEROTH, A., and STASS, S., Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation. Brit. J. Haematol., 82, 708-714 (1992).
12. LIVAK, K.J., FLOOD, J.A., MARMARO, J., GIUSTI, W., and DEETZ, K., Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl., 4, 357-362 (1995).
13. MARTIAT, P., MAISIN, D., PHILIPPE, M., FERRANT, A., MICHAUX, J.L., CASSIMAN, J.J., VAN DEN BERGHE, H., and SOKAL, G., Detection of residual bcr-abl transcripts in chronic myeloid leukemia patients in complete remission using the polymerase chain reaction and nested primers. Brit. J. Haematol., 75, 355-358 (1990).
14. MELO, J.V., The molecular biology of chronic myelogenous leukemia. Leukemia, 10, 751-756 (1996).
15. MELO, J.V., YAN, X.H., DIAMOND, J., LIN, F., CROSS, N.C.P., GOLDMAN, J.M., Reverse transcription/polymerase chain reaction (RT/PCR) amplification of very small numbers of transcripts: The risk of misinterpreting negative results. Leukemia, 10, 1217-1221 (1996).
16. MULLER, A.J., YOUNG, J.C., PENDERGAST, A.M., PONDEL, M., LANDAU, N.R., LITTMAN, D.R., and WITTE, O.N., BCR first exonsequences specifically activate the bcr/abl tyrosine kinase oncogene of philadelphia chromosome positive human leukemia. Mol. Cell Biol., 11, 1785-1792 (1991).
17. NOWELL, P.C. and HUNGERFORD, D.A., A minute chromosome in human chronic granulocytic leukemia. Science, 132, 1497-1499 (1960).
18. PIGNON, J.M., HENNI, T., AMSELEM, S., VIDAUD, M., DUQUESNOY, P., VERNANT, J.P., KUENTZ, M., CORDONNIER, C., ROCHANT, H., and GOOSENS, M., Frequent detection of minimal residual disease by use of polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia. Leukemia, 4, 83-86 (1990).
19. RADICH, J.P., and 14 OTHERS, Polymerase chain reaction detection of the bcr-abl fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: Results and implications in 346 patients. Blood, 85, 2632-2638 (1995).
20. ROTH, M.S., ANTIN, J.H., BINGHAM, E.L., and GINSBURG, D., Detection of philadephia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood, 74, 882-885 (1989).
21. ROWLEY, J.D., A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature (Lond.), 243, 290-293 (1973).
22. SHTIVELMAN, E., GALE, R.P., DREAZEN, O., BERREBI, A., ZAIZOV, R., KUBONISHI, I, MIYOSHI, I., and CANAANI, E., bcr-abl RNA in patients with chronic myelogenous leukemia. Blood, 69, 971-273 (1987).
23. SOUTAR, R.L., DILLON, J., and RALSTON, S.H., Control genes for reverse-transcription-polymerase chain reaction: A comparison of beta actin and glyceraldehyde phosphate dehydrogenase. Brit. J. Haematol., 97, 239-251 (1997).
24. STOCK, W., WESTBROOK, C.A., PETERSON, B., ARTHUR, D.C., SZATROWSKI, T.P., SILVER, R.T., SHER, D.A., WU, D., LE BEAU, M.M., SCHIFFER, C.A., and BLOOMFIELD, C.D., Value of molecular monitoring during the treatment of chronic myeloid leukemia: A cancer and leukemia group B study. J. Clin. Oncol., 15, 26-36 (1997).
25. VERSCHRAEGEN, C.F., TALPAZ, M., HIRSCH-GINSBERG, C.F., PHERWANI, R., RIOS, M.B., STASS, S.A., and KANTARJIAN, H.M., Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia. Blood, 85, 2705-2710 (1995).